David L Paterson (David Paterson)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 32

Top Topics

Escherichia Coli

Multidrug Resistant

Top Venues

Microbiology spectrum

JAC-antimicrobial resistance

Antimicrobial agents and chemotherapy

The Journal of antimicrobial chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Abdullah Tarik Aslan, David L Paterson
Epidemiology and clinical significance of carbapenemases in Australia: a narrative review. Internal medicine journal 54 (4) (2024)
Melissa Hardy, Patrick N A Harris, David L Paterson, Mark D Chatfield, Yin Mo, null null
Win Ratio Analyses of Piperacillin-Tazobactam Versus Meropenem for Ceftriaxone-Nonsusceptible Escherichia coli or Klebsiella pneumoniae Bloodstream Infections: Post Hoc Insights From the MERINO Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 78 (6) (2024)
Abdullah Tarik Aslan, David L Paterson
Epidemiology and clinical significance of carbapenemases in Australia: a narrative review. Internal medicine journal (2024)
Abdullah Tarik Aslan, David L Paterson
Epidemiology and clinical significance of carbapenemases in Australia: a narrative review. Internal medicine journal 54 (4) (2024)
Melissa Hardy, Patrick N A Harris, David L Paterson, Mark D Chatfield, Yin Mo, null null
Win ratio analyses of piperacillin-tazobactam versus meropenem for ceftriaxone non-susceptible Escherichia coli or Klebsiella pneumoniae bloodstream infections: Post-hoc insights from the MERINO trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Rusheng Chew, Marion L Woods, David L Paterson
Development and validation of supervised machine learning multivariable prediction models for the diagnosis of Pneumocystis jirovecii pneumonia using nasopharyngeal swab PCR in adults in a low-HIV prevalence setting. International health (2024)
Budi Permana, Patrick N A Harris, Naomi Runnegar, Margaret Lindsay, Belinda C Henderson, E G Playford, David L Paterson, Scott A Beatson, Brian M Forde
Using Genomics To Investigate an Outbreak of Vancomycin-Resistant Enterococcus faecium ST78 at a Large Tertiary Hospital in Queensland. Microbiology spectrum (2023)
Yin Mo, Ying Ding, Yang Cao, Jill Hopkins, Elizabeth A Ashley, Naomi Waithira, Prapass Wannapinij, Sue J Lee, Claire L Ling, Raph Leonardus Hamers, Tamalee Roberts, Yoel Lubell, Abhilasha Karkey, Samuel Akech, Samantha Lissauer, Japheth Opintan, Iruka N Okeke, Sergey Eremin, Barbara Tornimbene, Li Yang Hsu, Catherine Louise Thwaites, Minh Yen Lam, Ngoc Thach Pham, Tieu Kieu Pham, Jeanette Teo, Andrea Lay-Hoon Kwa, Kalisvar Marimuthu, Oon Tek Ng, Shawn Vasoo, Suwatthiya Kitsaran, Siriluck Anunnatsiri, Pope Kosalaraksa, Darunee Chotiprasitsakul, Pitak Santanirand, Rongpong Plongla, Hock Hin Chua, Xun Ting Tiong, Ke Juin Wong, Sasheela Sri La Sri Ponnampalavanar, Helmi Bin Sulaiman, Mohd Zulfakar Mazlan, Zeti Norfidiyati Salmuna, Giri Shan Rajahram, Mohd Zaki Bin Mohd Zaili, Joshua R Francis, Nevio Sarmento, Helio Guterres, Tessa Oakley, Jennifer Yan, Ari Tilman, Muhammad Osama Rehman Khalid, Madiha Hashmi, Syed Faisal Mahmood, Azizullah Khan Dhiloo, Ambreen Fatima, Inke Nadia D Lubis, Hendri Wijaya, Cybele L Abad, Arthur Dessi Roman, Cecilia C Maramba Lazarte, Gazi Md Salahuddin Mamun, Rosmonaliza Asli, Muhd Haziq Fikry Bin Haji Abdul Momin, Khurelbaatar Nyamdavaa, Ulziijargal Gurjav, Sotharith Bory, George M Varghese, Lalit Gupta, Pratik Tantia, Robert Sinto, Yohei Doi, Basudha Khanal, Greco Malijan, Jezreel Lazaro, Samanmalee Gunasekara, Sumudu Withanage, Po Yu Liu, Yonghong Xiao, Minggui Wang, David L Paterson, Hindrik Rogier van Doorn, Paul Turner
ACORN (A Clinically-Oriented Antimicrobial Resistance Surveillance Network) II: protocol for case based antimicrobial resistance surveillance. Wellcome open research 8 (2023)
Mark A T Blaskovich, Karl A Hansford, Mark S Butler, Soumya Ramu, Angela M Kavanagh, Angie M Jarrad, Anggia Prasetyoputri, Miranda E Pitt, Johnny X Huang, Fredrik Lindahl, Zyta Maria Ziora, Tanya Bradford, Craig Muldoon, Premraj Rajaratnam, Ruby Pelingon, David J Edwards, Bing Zhang, Maite Amado, Alysha G Elliott, Johannes Zuegg, Lachlan J M Coin, Anne-Kathrin Woischnig, Nina Khanna, Elena Breidenstein, Anna Stincone, Clive S Mason, Nawaz Khan, Hye Kyung Cho, Melissa J Karau, Kerryl E Greenwood-Quaintance, Robin Patel, Mandy Wootton, Meagan L James, Melanie L Hutton, Dena Lyras, Abiodun David Ogunniyi, Layla K Mahdi, Darren J Trott, Xiaoqian Wu, Samantha Niles, Kim Lewis, Jordan R Smith, Katie E Barber, Juwon Yim, Seth Alan Rice, Michael Joseph Rybak, Chad R Ishmael, Kellyn R Hori, Nicholas M Bernthal, Kevin P Francis, Jason A Roberts, David L Paterson, Matthew A Cooper
A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections. Science translational medicine 14 (662) (2022)
David L Paterson, Matteo Bassetti, Mary Motyl, Matthew G Johnson, Mariana Castanheira, Erin H Jensen, Jennifer A Huntington, Brian Yu, Dominik J Wolf, Christopher J Bruno
Ceftolozane/tazobactam for hospital-acquired/ventilator-associated bacterial pneumonia due to ESBL-producing Enterobacterales: a subgroup analysis of the ASPECT-NP clinical trial. The Journal of antimicrobial chemotherapy 77 (9) (2022)
Michael Kwok, Stephen McGeorge, Johanna Mayer-Coverdale, Bianca Graves, David L Paterson, Patrick N A Harris, Rachel Esler, Caroline Dowling, Sumudu Britton, Matthew John Roberts
Guideline of guidelines: management of recurrent urinary tract infections in women. BJU international (2022)
Kevin B Laupland, David L Paterson, Felicity Edwards, Adam G Stewart, Patrick N A Harris
Morganella morganii, an Emerging Cause of Bloodstream Infections. Microbiology spectrum 10 (3) (2022)
Michelle J Bauer, Anna Maria Peri, Lukas Lüftinger, Stephan Beisken, Haakon Bergh, Brian M Forde, Cameron Buckley, Thom Cuddihy, Patrice Tan, David L Paterson, David M Whiley, Patrick N A Harris
Optimized Method for Bacterial Nucleic Acid Extraction from Positive Blood Culture Broth for Whole-Genome Sequencing, Resistance Phenotype Prediction, and Downstream Molecular Applications. Journal of clinical microbiology 60 (11) (2022)
Minyon L Avent, Kate L McCarthy, Fekade Bruck Sime, Saiyuri Naicker, Aaron J Heffernan, Steven C Wallis, David L Paterson, Jason Alexander Roberts
Evaluating Mono- and Combination Therapy of Meropenem and Amikacin against Pseudomonas aeruginosa Bacteremia in the Hollow-Fiber Infection Model. Microbiology spectrum 10 (3) (2022)
Adam G Stewart, Burcu Isler, David L Paterson
An Australian perspective on antimicrobial stewardship programs and transplantation. Transplant infectious disease : an official journal of the Transplantation Society 24 (5) (2022)
Ama Ranasinghe, Andrew Henderson, Kyra Cottrell, Cindy S E Tan, Delaney Burnard, Hideo Kato, David L Paterson, Patrick N A Harris
Determining the in vitro susceptibility of tebipenem, an oral carbapenem, against third-generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolated from bloodstream infections. JAC-antimicrobial resistance 4 (5) (2022)
Delaney Burnard, Michelle J Bauer, Caitlin Falconer, Ian Gassiep, Robert E Norton, David L Paterson, Patrick N A Harris
Clinical Burkholderia pseudomallei isolates from north Queensland carry diverse bimABm genes that are associated with central nervous system disease and are phylogenomically distinct from other Australian strains. PLoS neglected tropical diseases 16 (6) (2022)
Abdulrahman K S Ayfan, Joanne Macdonald, Adam David Irwin, Hosam M Zowawi, Brian M Forde, David L Paterson, Monica M Lahra, David M Whiley
Proof-of-concept, rapid, instrument-free molecular detection of Neisseria gonorrhoeae and ciprofloxacin susceptibility. The Journal of antimicrobial chemotherapy 77 (11) (2022)
María Patricia Hernández-Mitre, Steven Y C Tong, Justin T Denholm, Gregory J Dore, Asha C Bowen, Sharon R Lewin, Balasubramanian Venkatesh, Thomas E Hills, Zoe K McQuilten, David L Paterson, Susan C Morpeth, Jason Alexander Roberts
Nafamostat Mesylate for Treatment of COVID-19 in Hospitalised Patients: A Structured, Narrative Review. Clinical pharmacokinetics 61 (10) (2022)
Weiping Ling, Luis Furuya-Kanamori, Yukiko Ezure, Patrick N A Harris, David L Paterson
Adverse clinical outcomes associated with infections by Enterobacterales producing ESBL (ESBL-E): a systematic review and meta-analysis. JAC-antimicrobial resistance 3 (2) (2021)
Valentine Murigneux, Leah W Roberts, Brian M Forde, Minh Duy Phan, Nguyen Thi Khanh Nhu, Adam David Irwin, Patrick N A Harris, David L Paterson, Mark A Schembri, David M Whiley, Scott A Beatson
MicroPIPE: validating an end-to-end workflow for high-quality complete bacterial genome construction. BMC genomics 22 (1) (2021)
Minh Duy Phan, Kate M Peters, Laura Alvarez Fraga, Steven C Wallis, Steven J Hancock, Nguyen Thi Khanh Nhu, Brian M Forde, Michelle J Bauer, David L Paterson, Scott A Beatson, Jeffrey Lipman, Mark A Schembri
Plasmid-mediated ciprofloxacin resistance imparts a selective advantage on Escherichia coli ST131. Antimicrobial agents and chemotherapy (2021)
Adam G Stewart, Andrew Henderson, Michelle J Bauer, David L Paterson, Patrick N A Harris
Activity of temocillin against third-generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae bloodstream isolates from a clinical trial. JAC-antimicrobial resistance 4 (1) (2021)
David L Paterson, Claire M Rickard
Letter From Australia: A Never-Ending Pandemic? Annals of internal medicine (2021)
Adam G Stewart, Kyra Cottrell, Andrew Henderson, Kanthi Vemuri, Michelle J Bauer, David L Paterson, Patrick N A Harris
In Vitro Activity of Cefotetan against ESBL-Producing Escherichia coli and Klebsiella pneumoniae Bloodstream Isolates from the MERINO Trial. Microbiology spectrum 9 (1) (2021)
Delaney Burnard, Gemma Robertson, Andrew Henderson, Caitlin Falconer, Michelle J Bauer, Kyra Cottrell, Ian Gassiep, Robert Norton, David L Paterson, Patrick N A Harris
Burkholderia pseudomallei Clinical Isolates Are Highly Susceptible In Vitro to Cefiderocol, a Siderophore Cephalosporin. Antimicrobial agents and chemotherapy 65 (2) (2021)
Weiping Ling, Luis Furuya-Kanamori, Yukiko Ezure, Patrick N A Harris, David L Paterson
Adverse clinical outcomes associated with carbapenem-resistant Acinetobacter (CRA) infections: a systematic review and meta-analysis. JAC-antimicrobial resistance 3 (4) (2021)
Burcu Isler, Patrick N A Harris, Adam G Stewart, David L Paterson
An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa--authors' response. The Journal of antimicrobial chemotherapy 76 (12) (2021)
Louisa G Gordon, Thomas M Elliott, Brian M Forde, Brett G Mitchell, Philip L Russo, David L Paterson, Patrick N A Harris
Budget impact analysis of routinely using whole-genomic sequencing of six multidrug-resistant bacterial pathogens in Queensland, Australia. BMJ open 11 (2) (2021)
Burcu Isler, Yukiko Ezure, Jose Luis García-Fogeda Romero, Patrick Harris, Adam G Stewart, David L Paterson
Is Ceftazidime/Avibactam an Option for Serious Infections Due to Extended-Spectrum-β-Lactamase- and AmpC-Producing Enterobacterales?: a Systematic Review and Meta-analysis. Antimicrobial agents and chemotherapy 65 (1) (2020)
Mark S Butler, David L Paterson
Antibiotics in the clinical pipeline in October 2019. The Journal of antibiotics 73 (6) (2020)
Matthew John Roberts, Alastair Macdonald, Sachinka Ranasinghe, Harrison Bennett, Patrick E Teloken, Patrick N A Harris, David L Paterson, Geoff Coughlin, Nigel Dunglison, Rachel Esler, Robert A Gardiner, Thomas M Elliott, Louisa G Gordon, John Yaxley
Transrectal versus transperineal prostate biopsy under intravenous anaesthesia: a clinical, microbiological and cost analysis of 2048 cases over 11 years at a tertiary institution. Prostate cancer and prostatic diseases 24 (1) (2020)